💥 #Topic on "Advanced Biomass Pretreatment and Bioconversion in Biofuels and Bioproducts Production" is open for submissions! 🔗 brnw.ch/21x3c3y @Biomass_MDPI, @Molecules_MDPI, @Catalysts_MDPI, @Energies_MDPI, @Processes_MDPI #mdpienergies #openaccess #callforpapers

TERRAMAR, an innovative technology produced through the bioconversion of #kelp and #leonardite, enhances compatibility in #fertilizer systems to reduce #plantstress and promote #planthealth. 🌳 See how it increased #almond yield and #iron content. hubs.ly/Q04jbRv80

📢Probiotic-based fermentation of watermelon waste: Effects on bioconversion efficiency, microbial shifts, and expression profiles of black soldier fly larvae Fareed Uddin Memon et al. 🔗doi.org/10.1111/1744-7917.70…

According to research, 8 - 10% of Green house gases annually are caused by organic food waste which could be naturally bio converted to protein rich feed and Frass. Our work supports Rwanda’s climate strategy 2035 ( reducing 53% GHG) via bioconversion and semi automation.

Publication Alert 🌱 Our new paper in Waste and Biomass Valorization investigates the valorization of waste milk and dairy manure through black soldier fly larval bioconversion.

📣 New #Topic "Advanced Biomass Pretreatment and Bioconversion in Biofuels and Bioproducts Production" is open for submissions! 🔗 brnw.ch/21x31Pp 📅 Abstract Submission Deadline: 10 March 2027 📅 Manuscript Submission Deadline: 10 May 2027 @MDPIEngineering

📢New Topic: Advanced Biomass Pretreatment and Bioconversion in #Biofuels and Bioproducts Production 🤝Together with @Catalysts_MDPI, @energies_mdpi, @Molecules_MDPI and @Processes_MDPI 🔗More Information: mdpi.com/topics/FN8945HPU6

I wonder how many are in the class annually, and how many universities are involved. So messed up...these people advancing the bioconversion of man think they're immune? Book smart but absolute FOOLS!

La mosca soldado negra (Hermetia illucens) transforma residuos orgánicos en proteína y aceite en solo 12-14 días. Un proceso de bioconversión eficiente que también genera abono orgánico. #Bioconversion #Sostenibilidad #EconomiaCircular

Prof. Stefano Campanaro from University of Padova presented the Bioconversion process optimization and microbial resource management of CRONUS project.

Beyond building a sustainable ecosystem through bioconversion and waste reduction, we also believe real impact should be felt directly by people and the environment. That’s why EGGMPIRE is committed to CSR initiatives: providing eggs to communities, supporting better nutrition, and planting thousands of trees as part of a long-term environmental mission. Because sustainability isn’t just about reducing emissions. It’s about creating a system that gives back.

🚨 Research Associate Walk-in @ IBSD Imphal Project Sustainable bioconversion of Phumdi biomass into fermentable sugars from Loktak Lake, Manipur Qualification PhD/MSc in Microbiology/Biotechnology/Biochemistry/Life Sciences helpbiotech.co.in/2026/05/ib… @DBT_IBSD #BiotechJobs

Gujarat Themis Biosyn to acquire Japan-based MicroBiopharm Japan for ~₹1,300 Cr 🇯🇵💊 • Acquisition to be done through wholly-owned subsidiary Themis Biosyn Japan Ltd • Deal value stands at JPY 21.5 Billion (~₹1,300 Cr), funded through debt and equity • MBJ specializes in APIs, intermediates and CDMO services with strong biotechnology and microbial fermentation capabilities • MBJ portfolio includes oncology APIs, plasmid DNA manufacturing, ADC conjugation and enzyme-based bioconversion • Acquisition strengthens GTBL’s presence in global biotech and fermentation-based pharmaceutical manufacturing

Gujarat Themis Biosyn Limited (GTBL) has entered into a definitive agreement to acquire 100% equity shareholding of MicroBiopharm Japan Co., Ltd. (MBJ) 🇯🇵 through its wholly-owned subsidiary, Themis Biosyn Japan Limited. This strategic acquisition is set to cost JPY 21.5 Billion (approximately ₹1,300 Crores), funded by a mix of debt & equity. 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: - 𝗧𝗮𝗿𝗴𝗲𝘁 𝗖𝗼𝗺𝗽𝗮𝗻𝘆: MicroBiopharm Japan Co., Ltd. (MBJ) is a Japan-based pharmaceutical firm specializing in R&D and manufacturing of APIs, intermediates, & CDMO services. It boasts strong capabilities in microbial fermentation & biotechnology. - 𝗠𝗕𝗝'𝘀 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀: MBJ has a diversified portfolio including oncology APIs, plasmid DNA manufacturing, ADC conjugation, & enzyme-based bioconversion. It has over six decades of experience in fermentation & microbial research. - 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹𝘀 𝗼𝗳 𝗠𝗕𝗝: ▸ Estimated Revenue FY26E: JPY 9.5 Billion (approx. ₹570 Crores) 📈 ▸ Revenue FY23: JPY 7,827 Million (approx. ₹470 Crores) ▸ Revenue FY24: JPY 9,741 Million (approx. ₹580 Crores) ▸ Revenue FY25: JPY 9,312 Million (approx. ₹560 Crores) - 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗥𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗲: This acquisition marks a significant step in GTBL's long-term strategy to transition from a fermentation-led intermediates business to a technology-driven Contract Development Manufacturing Organization (CDMO) platform, expanding its capabilities in precision fermentation, biotechnology, & next-gen drug manufacturing 🚀. - 𝗧𝗿𝗮𝗻𝘀𝗮𝗰𝘁𝗶𝗼𝗻 𝗗𝗲𝘁𝗮𝗶𝗹𝘀: ▸ Acquisition Type: 100% equity stake. ▸ Consideration: JPY 21.5 Billion (approx. ₹1,300 Crores). ▸ Funding: Optimal mix of debt & equity. ▸ Not a related party transaction. - 𝗧𝗶𝗺𝗲𝗹𝗶𝗻𝗲: The acquisition is expected to close in Q2 FY2027, subject to customary closing conditions & necessary regulatory approvals, including approval under Japan's Foreign Exchange and Foreign Trade Act (FEFTA) ✅. 📊 GUJARAT THEMIS BIOSYN LTD | 🏷️ Acquisition 🌐 Details: wegro.app/DqAKbw ⚡️Instant stock alerts on WhatsApp - Try FREE 👉 wegro.app/go

✨Editor's Choice Article! Environmental Performance of Hermetia illucens Bioconversion in a Medium-Scale Mass Rearing System to Valorize Agri-Food Industrial Residue Read at 👉mdpi.com/2071-1050/17/21/965… #AgriFood #LifeCycleAssessment #Bioconversion #OpenAccess #Sustainability

Recent advancements in butyric acid research: health effects, sources, and high-efficiency bioconversion production strategies sciopen.com/article/10.26599…